Trials / Terminated
TerminatedNCT00205049
Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to placebo in AAH while studying putative mechanisms that are plausible and testable. The main hypothesis is that pentoxifylline reduces the 90-day mortality of AAH.
Detailed description
The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to placebo in AAH while studying putative mechanisms that are plausible and testable. The main hypothesis is that pentoxifylline reduces the 90-day mortality of AAH. This study never moved forward due to funding issues.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pentoxifylline | daily dosing |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2005-09-20
- Last updated
- 2014-05-13
- Results posted
- 2014-05-13
Source: ClinicalTrials.gov record NCT00205049. Inclusion in this directory is not an endorsement.